海圣医疗
(920166)
| 流通市值：0.00万 | | | 总市值：0.00万 |
| 流通股本：0.00万 | | | 总股本：0.00万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 247,713,864.91 | 155,630,576.44 | 63,617,860.85 | 303,733,542.26 |
| 营业收入 | 247,713,864.91 | 155,630,576.44 | 63,617,860.85 | 303,733,542.26 |
| 二、营业总成本 | 183,344,742.23 | 116,750,139.13 | 50,738,091.82 | 226,364,545.66 |
| 营业成本 | 119,785,337.66 | 75,337,102.83 | 31,387,845.6 | 145,516,381.82 |
| 税金及附加 | 3,060,112.85 | 1,890,441.1 | 737,206.28 | 3,939,301.74 |
| 销售费用 | 26,181,834.22 | 16,536,884.07 | 7,490,513.69 | 32,688,305.61 |
| 管理费用 | 21,255,762.49 | 14,460,904.97 | 6,727,175.65 | 28,987,640.21 |
| 研发费用 | 13,047,517.85 | 8,629,983.67 | 4,472,192.54 | 16,157,789.8 |
| 财务费用 | 14,177.16 | -105,177.51 | -76,841.94 | -924,873.52 |
| 其中:利息费用 | 10,038 | 7,593.71 | 4,245.4 | 373,229.26 |
| 其中:利息收入 | 232,327.22 | 176,975 | 98,088.48 | 1,130,073.49 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 65.87 | 65.87 | - | - |
| 资产处置收益 | - | - | - | -6,113.4 |
| 资产减值损失(新) | -153,156.29 | -109,364.77 | -207,040.48 | -214,786.5 |
| 信用减值损失(新) | -60,989.12 | 39,206.79 | 466,188.84 | -136,977.52 |
| 其他收益 | 3,151,501.98 | 1,422,132.42 | 357,690.96 | 4,249,021.07 |
| 四、营业利润 | 67,306,545.12 | 40,232,477.62 | 13,496,608.35 | 81,260,140.25 |
| 加:营业外收入 | 25,681.55 | 25,681.55 | 2,600 | 124,146.86 |
| 减:营业外支出 | 455,375.81 | 39.48 | - | 30,080.34 |
| 五、利润总额 | 66,876,850.86 | 40,258,119.69 | 13,499,208.35 | 81,354,206.77 |
| 减:所得税费用 | 8,094,836.98 | 4,763,948.93 | 1,663,951.8 | 10,436,679.17 |
| 六、净利润 | 58,782,013.88 | 35,494,170.76 | 11,835,256.55 | 70,917,527.6 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 58,782,013.88 | 35,494,170.76 | 11,835,256.55 | 70,917,527.6 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 58,782,013.88 | 35,494,170.76 | 11,835,256.55 | 70,917,527.6 |
| 扣除非经常损益后的净利润 | 56,845,030.99 | 34,638,490.67 | 11,748,046.55 | 68,036,244.35 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.92 | 0.55 | 0.18 | 1.11 |
| (二)稀释每股收益 | 0.92 | 0.55 | 0.18 | 1.11 |
| 九、综合收益总额 | 58,782,013.88 | 35,494,170.76 | 11,835,256.55 | 70,917,527.6 |
| 归属于母公司股东的综合收益总额 | 58,782,013.88 | 35,494,170.76 | 11,835,256.55 | 70,917,527.6 |
| 公告日期 | 2025-11-03 | 2025-08-15 | 2025-05-12 | 2025-04-11 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |